Aloxi
NDC Package 62856-798-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Aloxi is a medication used to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). Marketed by Eisai Inc., this product is identified by NDC 62856-798 and is authorized under FDA application NDA021372.

Identification & Billing

NDC Package Code
62856-798-01
Package Description
5 VIAL in 1 CARTON / 1.5 mL in 1 VIAL
Product Code
62856-798
11-Digit Billing Format
62856079801

Clinical Specifications

Proprietary Name
Aloxi
Dosage Form
-
Usage Information
This medication is used to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). It is also used to prevent nausea and vomiting after surgery. Palonosetron works by blocking one of the body's natural substances (serotonin) that causes vomiting.

Regulatory & Marketing

Labeler Name
Eisai Inc.
FDA Application #
NDA021372
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
05-28-2014
End Marketing Date
10-31-2022
Listing Expiration
10-31-2022
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 62856-798-01 identifies a specific commercial package of 5 vial in 1 carton / 1.5 ml in 1 vial of Aloxi, labeled by Eisai Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Eisai Inc. on May 28, 2014. The current certification is valid through October 31, 2022.

What are the primary indications for this medication?

This medication is used to prevent nausea and vomiting caused by cancer drug treatment (chemotherapy). It is also used to prevent nausea and vomiting after surgery. Palonosetron works by blocking one of the body's natural substances (serotonin) that causes vomiting.

How is this Eisai Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 62856079801. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
62856-798-01
11-Digit CMS (5-4-2)
62856-0798-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.